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Abstract: This study aimed to investigate the cardiovascular effects elicited by Dictyota 
pulchella, a brown alga, using in vivo and in vitro approaches. In normotensive conscious 
rats, CH2Cl2/MeOH Extract (CME, 5, 10, 20 and 40 mg/kg) from Dictyota pulchella 
produced dose-dependent hypotension (−4 ± 1; −8 ± 2; −53 ± 8 and −63 ± 3 mmHg) and 
bradycardia (−8 ± 6; −17 ± 11; −257 ± 36 and −285 ± 27 b.p.m.). In addition, CME and 
Hexane/EtOAc Phase (HEP) (0.01–300 µg/mL) from Dictyota pulchella induced a 
concentration-dependent relaxation in phenylephrine (Phe, 1 µM)-pre-contracted mesenteric 
artery rings. The vasorelaxant effect was not modified by the removal of the vascular 
endothelium or pre-incubation with KCl (20 mM), tetraethylammonium (TEA, 3 mM)   
or tromboxane A2 agonist U-46619 (100 nM). Furthermore, CME and HEP reversed 
CaCl2-induced vascular contractions. These results suggest that both CME and HEP act on 
the voltage-operated calcium channel in order to produce vasorelaxation. In addition, CME 
induced vasodilatation after the vessels have been pre-contracted with L-type Ca
2+  
channel agonist (Bay K 8644, 200 nM). Taken together, our data show that CME   
induces hypotension and bradycardia in vivo and that both CME and HEP induce 
endothelium-independent vasodilatation in vitro that seems to involve the inhibition of the 
Ca
2+ influx through blockade of voltage-operated calcium channels. 
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1. Introduction  
Marine algae are recognized as rich sources of structurally-diverse-biologically-active compounds 
with great pharmaceutical and biomedical potentials. Researchers worldwide have demonstrated   
that marine algae derived compounds exhibit various biological activities such as anticoagulant [1,2], 
anti-viral [3,4], antioxidant [5,6], anti-allergic [7], anti-cancer [8,9] and as adjuvants for treating 
cardiopathies [10]. Despite the ascending number of new findings regarding marine algae metabolites 
possessing biological activity in the last three decades, few products showing real pharmaceutical 
potential have been identified or developed [11,12]. 
Marine brown algae have innumerous families, with the Dictyotaceae family being the best studied 
among them. The genus Dictyota is represented by more than 40 species, thus being the richest   
genus of the Dictyotaceae family. It is also one of the most abundant seaweeds in tropical marine 
habitats. The Dictyotaceae family produces a signiﬁcant number of secondary metabolites, especially 
diterpenes [13]. Terpenoids constitute the largest family of natural products [14,15] and are classified 
by the homologous series of number of five carbon isoprene units in their structure: hemiterpenes C5  
(1 isoprene unit), monoterpenes C10 (2 isoprene units), sesquiterpenes C15 (3 isoprene units), diterpenes 
C20 (4 isoprene units), triterpenes C30 (6 isoprene units) [16]. 
Many reports have extensively shown that several classes of diterpenoids exert signiﬁcant 
cardiovascular effects [17–19]. It has also been reported that some classes of diterpenes showed 
significant systemic hypotensive and coronary vasodilatory effects accompanied by gradual decrease 
in heart rate [20,21]. The studies pointed at diterpenoids as promising sources for new prototypes in 
the discovery and development of novel cardiovascular therapeutic agents [19]. 
Cardiovascular diseases are the leading death cause in developed and developing countries [22], 
causing a great impact not only on human health, but also in social and economic areas. In an attempt 
to reduce this impact, several research groups in recent decades have worked extensively to   
improve the treatment of cardiovascular diseases including the discovery of new therapy strategies and 
drugs [23,24]. 
Considering that marine algae constitute great sources of bioactive compounds, the aim of this 
study was to investigate the mechanisms underlying the cardiovascular effects induced by the brown 
algae Dictyota pulchella in rats. To reach that goal, we employed in vivo and in vitro approaches. 
2. Results and Discussion  
2.1. Dictyota pulchella Elicits Hypotension and Bradycardia in Rats 
Mean arterial pressure (MAP) and heart rate (HR) were recorded before (baseline) and after 
intravenous administration of CH2Cl2/MeOH extract from Dictyota pulchella (CME, 5, 10, 20 and  
40 mg/kg body weight, randomly) in conscious normotensive rats. CME elicited a dose-dependent Mar. Drugs 2011, 9                                  
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hypotension (−4 ± 1; −8 ± 2; −53 ± 8 and −63 ± 3 mmHg) and bradycardia (−8 ± 6; −17 ± 11; −257 ± 36 
and −285 ± 27 b.p.m.) as illustrated in Figure 1A,B. 
Figure 1. ( A) Representative original tracings showing the changes in pulse arterial 
pressure (PAP, mmHg), mean arterial pressure (MAP, mmHg), and heart rate (HR, b.p.m.); 
(B) Changes in mean arterial pressure (MAP) and heart rate (HR) induced by the acute 
administration of increasing doses of CME (mg/kg, i.v) and vehicle. Values are expressed 
by mean ± SEM. (n = 5).  
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It is well-known that anesthesia modifies the levels of blood pressure and heart rate interfering with 
central regulatory mechanisms involved in BP regulation, such as the baroreflex, by producing 
depression of the central nervous system synapses, altering the autonomic responses [25]. In order to 
avoid the possible influence of anesthesia and surgical stress on cardiovascular parameters [26], our 
studies were carried out in conscious freely moving rats.  Mar. Drugs 2011, 9                                  
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In the present study, the acute administration of CME induced marked hypotension and bradycardia 
in conscious rats (Figure 1B). It is important to note that reduction in blood pressure due to 
vasodilation is usually followed by reflex tachycardia. However, under our experimental conditions, in 
addition to hypotension, CME induced bradycardia, which could be explained, at least in part, by a 
possible direct effect of the CME on the heart. Although this is an interesting possibility, this 
hypothesis awaits further investigation. 
Although we demonstrated that CME can produce hypotension in normotensive rats, the   
beneficial effects of this marine algae on experimental hypertension and its clinical relevance still 
awaits further investigation. 
2.2. Dictyota pulchella Elicits Vasorelaxation Mediated by the Blockade of Calcium Influx in Isolated 
Mesenteric Artery Rings 
Based on the reports highlighting that the vascular smooth muscle tone plays an important role in 
maintaining blood pressure [27], we investigated the possible vasorelaxant effect elicited by Dictyota 
pulchella in isolated superior mesenteric arteries. An important layer in the regulation of vascular tone 
is the endothelium. For many years, this layer was considered to be an inert barrier that separated 
ﬂowing blood from underlying tissue. Over time, it has been established that the endothelium plays an 
active role in regulating hemostasis, cellular and nutrient trafﬁcking, and vasomotor tone [28]. 
Endothelial cells are able to produce both vasoconstrictive and vasodilating substances. The main 
endothelium-derived relaxing factors (EDRF) are nitric oxide, prostacyclin, and endothelium-derived 
hyperpolarizing factor (EDHF). Among the contracting factors are endothelin-1, thromboxane A2 and 
reactive oxygen species [29]. To evaluate the possible role played by the endothelium in the hypotension 
elicited by Dictyota pulchella observed in vivo, mesenteric artery rings were pre-contracted with 
phenylephrine (1 μM), a α1-adrenoceptors agonist. In the presence of this contracting agent, CME   
(0.01–500 µg/mL) induced a concentration-dependent relaxation (Maximum Response = 101.4 ± 4.5%; 
EC50 = 22.35 ± 5.09 µg/mL, n = 6) and this effect was not modified by vascular endothelium removal 
(Maximum Response = 103.3 ± 8.3%; EC50 = 21.43 ± 8.98 µg/mL, n = 6) (Figure 2A). Similar results 
were found in the presence of Hexane/EtOAc phase from Dictyota pulchella (HEP) (0.01–500 µg/mL), 
which induced a concentration-dependent vasodilatation in both intact (Maximum Response = 80.6 ± 5.8%; 
EC50 = 24.1 ± 8.95 µg/mL, n = 6) or denuded-endothelium (Maximum Response = 95.6 ± 7.5%;  
EC50 = 23.7 ± 5.65 µg/mL, n = 6) (Figure 2B).  
Potassium channels (K
+ channels) appear to play a crucial role in controlling the cellular membrane 
potential and in the vascular tone. Potassium channel openers exert their biological effects by 
increasing the probability of opening K
+ channels and a number of substances that act on K
+ channels 
have been shown to dilate arteries by causing hyperpolarization in vascular smooth muscle cells [30]. 
In addition several natural products have been shown to induce vasorelaxant effects through the 
activation of K
+ channels [31–33]. Aiming to investigate involvement of potassium channels (K
+) in 
the vasorelaxant activity elicited by CME, the preparations were pre-incubated with Tyrode’s modified 
solution containing KCl (20 mM) or with tetraethylammonium (TEA, 3 mM), a non-selective   
K
+ channel blocker. In both preparations, the vasorelaxant activity was not changed (Maximum 
Response = 102.3 ± 4.8%; EC50 = 25.40 ± 6.05 µg/mL; and Maximum Response = 111.2 ± 5.3%;  Mar. Drugs 2011, 9                                  
 
 
2079
CE50 = 16.70 ± 3.61 µg/mL; n = 7, respectively) as shown in Figure 3A. These responses were no 
different from the control curve, suggesting that K
+ channels are not involved in the vasorelaxant 
effect elicited by CME. 
Figure 2. Concentration–response curves showing the relaxant effect of (A) CME   
(0.01–500  µg/mL); and (B) Hexane/EtOAc Phase (HEP) (0.01–500 µg/mL) on Phe   
(1 µM)-pre-contracted mesenteric artery rings with (■, n = 7) and without (□, n = 7) 
vascular endothelium, respectively. Values are expressed by mean ± SEM. 
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Figure 3. Concentration–response curves showing the relaxant effect elicited by CME 
(0.01–500 µg/mL, n = 6) in the presence of (A) KCl (20 mM) (♦) or TEA 3 mM (○);  
(B) KCl (60 mM) (●) or U-46619; (□) represents phenyephrine pre-contracted mesenteric 
rings without endothelium; (C) Vasorelaxant effect elicited by HEP (0.01–500 µg/mL) on 
KCl 60 mM-pre-contracted mesenteric artery rings (●) and Phe (1 µM)-pre-contracted 
mesenteric rings without endothelium (n = 7). Values are expressed by mean ± SEM. 
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Figure 3. Cont. 
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To test the hypothesis that CME produces vasorelaxant effects independent of the vasoconstrictor 
agent used in the preparation, mesenteric artery rings were incubated with tromboxane A2 agonist  
U-46619 (100 nM). In the presence of U-46619, CME induced concentration-dependent vasodilatation 
(Maximum Response = 90.3 ± 7.8%; EC50 = 24.63 ± 4.04 µg/mL, n = 6) similar to the response found 
by Phe-contracted mesenteric artery rings (Figure 3B). 
In addition, CME produced relaxation in isolated arteries pre-contracted with KCl (60 mM). KCl 
depolarization elicits contraction by allowing the extracellular Ca
2+ influx through voltage-dependent 
(L- and T-type) Ca
2+ channels and subsequent calcium release from the sarcoplasmic reticulum. Due to 
the fact that the membrane potential is essentially clamped by the high K
+ solution, the mechanism by 
which relaxation can be produced is through blockade of voltage-dependent Ca
2+ channels, but not by 
other mediators that cause hyperpolarization [34]. After exposure to high concentrations of 
extracellular K
+ (KCl, 60 mM), CME induced concentration-dependent vasodilatation (Maximum 
Response = 97.7 ± 4.0%; EC50 = 34.57 ± 5.11 mg/mL; n = 6). Under the same experimental   
condition, HEP induced concentration-dependent vasodilatation (Maximum Response = 113.5 ± 6.1%; 
EC50 = 10.92 ± 2.81 µg/mL; n = 6) (Figure 3C). Furthermore, both CME and HEP relaxed arterial 
segments pre-contracted with KCl (60 mM) suggesting that CME and HEP block Ca
2+ entry through 
voltage-dependent Ca
2+ channels (Cav).  
In order to further investigate the hypothesis that CME and HEP act through the blockade of 
calcium influx, CME and HEP were tested in the presence of CaCl2-induced contractions in a 
depolarizing medium without calcium. This protocol was based on the fact that CaCl2-induced 
contractions are elicited, almost exclusively, through Ca
2+ influx, since the depolarization promoted by 
high concentrations of extracellular K
+ induces the opening of voltage-dependent Ca
2+ channels [35]. 
Under this experimental condition, CME and HEP (0.03; 0.3; 10; 30 and 100 µg/mL) produced a  
non-parallel and concentration-dependent rightward shift of the CaCl2 concentration–response curve 
significantly reducing the maximal response (Maximum Response = 116.1; 122.7; 84; 40.7; 7.6% and 
130; 126.2; 46.8; 22.8; 7.3%, respectively) as illustrated in Figure 4A,B. Mar. Drugs 2011, 9                                  
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Figure 4. Effects of (A) CME and (B) HEP on CaCl2-induced contraction in   
endothelium-denuded mesenteric artery rings. Concentration-response curves for CaCl2 
were determined in Ca
2+-free solution containing KCl (60 mM). The curves were 
determined in the absence (control, ■) and after incubation with CME in (A) or HEP in  
(B) (▼) 0.03; (●) 0.3; (Δ) 10; (◊) 30; (×) 100 µg/mL, n = 7. * Significantly different from 
control (p < 0.05). 
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Voltage-dependent calcium channels (Cav) are transmembrane proteins that provide influx of 
calcium for a variety of intracellular activities in excitable cells. In blood vessels, this calcium entry 
produces vasoconstriction and blockers of Cav have been used to treat cardiovascular disorders. 
Voltage-dependent calcium channels consist of different subunits: the α1-subunit, which contains four 
homologous transmembrane domains encompassing the pore, the voltage sensor and the selectivity 
filter; and the β, α2δ and γ auxiliary subunits. The α1-subunits have been classified as Cav1.1, Cav1.2, 
Cav1.3, Cav1.4 (L-type Cav), Cav2.1 (P/Q-type Cav), Cav2.2 (N-type Cav), Cav2.3 (R-type Cav), Cav3.1, 
Cav3.2 and Cav3.3 (T-type Cav). In the vascular smooth muscle cells two types are expressed: L-type Mar. Drugs 2011, 9                                  
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and T-type. The first ones are more expressed in these cells and exert an important role in the 
regulation of the vascular tone [36,37]. 
In order to examine which subtype of Cav was involved in the vasorelaxant effect elicited by   
CME, a contraction with Bay K 8644 (200 nM), a L-type Ca
2+ channel agonist, was evoked.   
CME induced concentration-dependent vasodilatation (Maximum Response = 113.3 ± 6.7%;   
EC50 = 19.45 ± 6.66 µg/mL, n = 7) and it was similar to the response found under Phe-induced 
contractions (Figure 5). These data indicate that L-type Cav channels could be involved in the 
vasorelaxant effect induced by CME.  
Figure 5. Effect of increasing concentrations of CME (0.01–500 µg/mL, n = 7) on 
phenylephrine (Phe, 1 µM) (□) or KCl (20 mM) plus S(−)-BayK 8644 (10
−7 M)   
(▲) induced contractions in isolated mesenteric artery rings without endothelium. Values 
are expressed by mean ± SEM. 
-2 -1 0 1 2 3
0
25
50
75
100
125
Phe (E
-)
KCl 20 mM +  Bay K 200 nM
Log [CME] g/mL
%
 
R
e
l
a
x
a
t
i
o
n
 
In order to investigate a role for dihydropyridine calcium channels, rings were incubated with 
nifedipine. In the presence of nifedipine, CME (0.01–500 µg/mL) induced a concentration-dependent 
relaxation (Maximum Response = 63.6 ± 2.9%; EC50 = 25.4 ± 11.0 µg/mL, n = 6). The maximum 
response was different to the response found by Phe-contracted mesenteric artery rings (Figure 6A). In 
addition, in the presence of nifedipine, HEP (0.01–500 µg/mL) induced a concentration-dependent 
relaxation (Maximum Response = 69.8 ± 1.7%; EC50 = 24.4 ± 10.3 µg/mL, n = 6). The maximum 
response was different to the response found by Phe-contracted mesenteric artery rings (Figure 6B). 
Based on these findings, it can be suggested that the endothelium-independent vasodilatation induced 
by both CME and HEP involves, at least in part, the inhibition of the Ca
2+ influx through blockade of 
calcium channels. Mar. Drugs 2011, 9                                  
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Figure 6. Concentration–response curves showing the relaxant effect elicited by (A) CME 
(0.01–500 µg/mL); and (B) HEP (0.01–500 µg/mL) in the presence of nifedipine (×, n = 6); 
(□) represents phenyephrine pre-contracted mesenteric rings without endothelium. Values 
are expressed by mean ± SEM. * Significantly different from control (p < 0.05). 
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3. Experimental Section  
3.1. Algal Material and Preparation of CH2Cl2/MeOH Extract (CME) and Hexane/EtOAc Phase 
(HEP) from Dictyota pulchella 
The brown alga Dictyota pulchella Hörnig and Schnetter (Dictyotaceae, Phaeophyceae) was 
collected at Bessa Beach, João Pessoa, State of Paraíba, Brazil, at coordinates 07°04’01’’S and 
34°49’35’’W in February 2009 at a depth of 1 m and it was identified by George Emmanuel C. de 
Miranda. A voucher specimen (JPB 41771) is deposited at Lauro Pires Xavier Herbarium of the 
Federal University of Paraíba. 
The freeze-dried material (240 g) was extracted with CH2Cl2/MeOH (2:1) at room temperature. The 
concentrated extract (10 g) was partitioned by vacuum filtration with silica gel that uses the solvents 
Hexano/EtOAc (9:1) to give the fraction Hexano/EtOAc (9:1) (850 mg). 
The CH2Cl2/MeOH extract (CME) and Hexane/EtOAc phase (HEP) were prepared in a mixture of 
distilled water (in vitro experiments) or NaCl 0.9 % solution (in vivo experiments) and cremophor 
(0.013% v/v) and kept at −4° C. The stock solution was diluted to the desired concentrations with 
distilled water or isotonic saline just before use. The ﬁnal concentration of cremophor in the bath had 
no effect when tested in control preparations (data not shown). 
3.2. Drugs and Solutions 
The following drugs were used: Cremophor EL, L-phenylephrine chloride (Phe), acetylcholine 
chloride (Ach), tetraethylammonium (TEA), S(−)-Bay K 8644, sodium nitroprusside, Ethylene   
glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA) and 9,11-Dideoxy-11α,9α-
epoxymethanoprostaglandin F2α (U 46619), were purchased from Sigma Chemical (Sigma Chemical Mar. Drugs 2011, 9                                  
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Co., St. Louis, MO, USA). Heparin sodium salt (Roche Brazil, São Paulo, Brazil), sodium thiopental 
(Cristália, São Paulo, SP, Brazil). The substances were dissolved in distilled water (in vitro 
experiments) or in NaCl 0.9% solution (in vivo experiments).  
The composition of the Tyrode’s solution used to bath isolated rings was (mM): NaCl, 158.3;  
KCl, 4.0; CaCl2, 2.0; MgCl2, 1.05; NaH2PO4, 0.42; NaHCO3, 10.0 and glucose, 5.6. 
3.3. Animals 
Male Wistar rats (250–300 g) were used in all experiments. They were housed in conditions of 
controlled temperature (21 ± 1 °C) and exposed to a 12 h light-dark cycle with free access to food 
(Labina
®, PURINA, Brazil) and tap water. All procedures described in the present study are in 
agreement with Institutional Animal Care and Use Committee of the Federal University of Paraiba 
(CEPA/LTF protocol No. 0208/10). 
3.4. In Vivo Experiments 
Intra-aortic blood pressure was recorded using a technique described by Braga [37] under sodium 
thiopental anesthesia (45 mg/kg, i.v.), the lower abdominal aorta and inferior vena cava were 
cannulated via left femoral artery and vein using polyethylene catheters. Thereafter, catheters were 
filled with heparinized saline solution and tunneled under the skin to emerge between the scapulae. 
Arterial pressure was measured 24 h after surgery by connecting the arterial catheter to a pre-calibrated 
pressure transducer (MLT0380/D, ADInstruments, Australia) and connected to a computer (Mikro-tip 
Blood pressure system, ADInstruments, Australia) running the LabChart software (ADInstruments, 
Australia). The data were sampled at 2000 Hz. For each pulse pressure, the computer calculated mean 
arterial pressure (MAP) and heart rate (HR). The venous catheter was used for drug administration.  
3.5. In Vitro Experiments 
3.5.1. Tissue Preparation 
Rats were euthanized by stunning and bleeding. The superior mesenteric artery was removed and 
cleaned from connective tissue and fat. Rings (1–2 mm) were obtained and placed in physiological 
Tyrode’s solution, maintained at 37 °C, gassed with carbogenic mixture (95% O2 and 5% CO2), and 
maintained at pH 7.4. All preparations were stabilized under a resting tension of 0.75 g for 1 h. The 
solution was replaced every 15 min to prevent the accumulation of metabolites. The force of contraction 
was isometrically recorded by a force transducer (MLT020, ADInstruments, Australia) connected to a 
data acquisition system (ML870/P with LabChart version 7.0, ADInstruments, Australia). Endothelium 
was removed by gently rubbing the intimal surface of the vessels.  
The presence of functional endothelium was assessed by the ability of acetylcholine (ACh) (10 µM) 
to induce more than 90% relaxation of pre-contracted vessels with phenylephrine (10 µM). When the 
relaxation to ACh was less than 10%, this was taken as evidence that the vessel segments were 
functionally denuded of endothelium. Mar. Drugs 2011, 9                                  
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3.5.2. Measurement of Vascular Relaxation Elicited by CME or HEP 
The ability of extract or phase to cause vascular relaxation was evaluated in both endothelium-intact 
and endothelium-denuded mesenteric artery rings previously contracted by Phe (1 μM). Under the 
sustained contraction elicited by Phe the vessels were exposed to cumulative concentrations of CME or 
HEP (3, 5, 10, 30 and 50 µg/mL).  
3.5.3. Effect of CME or HEP on KCl (60 mM) or U-46619 (100 nM)-Induced Contractions in Rings 
without Endothelium or after KCl (20 mM) and Tetraethylamonium (3 mM) Incubation 
Contractions of the vessels were induced with KCl (60 mM) or U-46619 (100 nM) in rings without 
the endothelium. During the tonic phase of the contraction, CME or HEP (0.01–500 µg/mL) was added 
to the organ bath. The extent of relaxation was expressed as the percentage of KCl- or U46619-induced 
contraction. Furthermore, curves for CME were obtained after incubation with KCl (20 mM) or TEA 
(3 mM), a non-selective K
+ channel blocker in rings without the endothelium. 
3.5.4. Depolarization Induced by High Extracellular K
+ Concentration 
In order to access the effects of CME or HEP on voltage-gated Ca
2+ channels, superior mesenteric 
artery rings were bathed for 15 min in Ca
2+-free Tyrode’s solution, prepared by omitting only CaCl2 
and then exposed for an additional 15 min to a high K
+ (60 mM) Ca
2+-free solution. Under this new 
experimental condition, cumulative concentration-response curves to CaCl2 (ranging from 1 μM to  
3 mM) were obtained. CME and HEP (0.01–500 µg/mL) were added to the preparations for 30 min, 
and then a new cumulative concentration–response curve for CaCl2 was determined. The maximal 
contraction obtained with the control concentration–response curve to CaCl2 was taken as 100% and 
all values were calculated as a percentage of the maximal response. Each preparation was exposed to 
only one CME or HEP-concentration. All experiments were done using endothelium-denuded superior 
mesenteric artery rings. 
3.5.5. Effect of CME on the Contraction Elicited by S(−)-Bay K 8644 (200 nM) or Nifedipine (1 µM) 
in Mesenteric Artery Rings without Endothelium 
Contractions of the vessels were induced by S(−)-Bay K 8644 (200 nM), an activator of calcium 
channels sensitive to dihydropyridines, in rings without the endothelium. During the tonic phase of the 
contraction, CME (0.01–500 µg/mL) was added to the organ bath. The extent of relaxation was 
expressed as the percentage of S(−)-Bay K 8644 -induced contraction. In addition, in order to 
intestigate the involvement of calcium channels, nifedipine (1 µM) was used to pre-incubate the 
preparations prior to CME or HEP administration. 
3.6. Statistical Analysis 
Data are expressed as the mean ± SEM. When appropriate, the significance of differences was 
determined using one-way ANOVA following Bonferroni’s post test with GraphPad Prism version 5.0 
(GraphPad Software, La Jolla, CA, USA). Throughout the results, the “maximal relaxation” Mar. Drugs 2011, 9                                  
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corresponds to the maximum response of pre-contracted tissues to the highest concentration of drug 
tested. P < 0.05 was considered significant. 
4. Conclusions  
Using combined in vivo and in vitro approaches, our data suggest that Dictyota pulchella induces 
hypotension and bradycardia. In addition, both extract and phase from Dictyota pulchella induce 
endothelium-independent vasodilatation that involves the inhibition of the Ca
2+ influx through blockade 
of voltage-operated calcium channels. More studies are needed in order to evaluate the effects of this 
marine alga on experimental models of diseases such as hypertension and heart failure, which will help 
to advance the field towards clinical trials. Eventually, these data will open new perspectives in the use 
of these marine brown algae for developing drugs targeting the cardiovascular system. 
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